MoneyWorks4Me

ANG Lifesciences informs about not applicability of large corporate entity

24 Apr 2025 Evaluate
With reference to the SEBI Circular -SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018, ANG Lifesciences has confirmed that the company is not falling under Large Corporate Category as on 31st March, 2025.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

32.87 0.00 (0.00%)
10-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.10
Dr. Reddys Labs. 1159.95
Cipla 1463.35
Lupin 2275.00
Zydus Lifesciences 1127.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: